1,-Glutamate is now well established as the predominant transmitter at fast-acting excitatory synapses in the mammalian central nervous system. Other amino acids such as L-aspartate and several acidic sulphur-containing amino acids (SAAs) which exhibit potent depolarizing actions similar to that of L- glutamate [I-31 are known to exist in the brain and/or are present in the brain under pathological conditions. The putative SAA transmitters (see Figure 1 ) comprise the L-aspartate analogues, L- cysteine sulphinate (CSA) and L-cysteate (CA), and the L-glutamate analogues, L-homocysteine sulphinate (HCSA), L-homocysteate (HCA) and S-sulpho-L-cysteine (SSC). Of these, evidence to support a neurotransmitter/neuromodulator role is most complete for CSA and HCA [4, 51. The SAAs or a disturbance in the metabolism of their precursors have been implicated in the pathogenesis of various neurological and neurodegenerative disorders (e.g. and they also appear to reproduce a similar range of excitotoxic properties to that of r>-glutamate-induced cell damage [ 10, 1 I], possibly mediated by glutamate receptor subtypes [12] [13] [14] .
Basic questions which arise concerning the role of amino acids in neurotransmission are: (i) does a particular neural pathway use the amino acid as a transmitter?; and (ii) what are the mechanisms of release, action and re-uptake? This overview deals primarily with the more recent data regarding the mechanism of SAA action and re-uptake, and highlights the signal transduction mechanisms by which the SAAs may exert their normal and pathogenic effects. The remaining aspects of the questions posed above are the subject of current 
Pharmacology of excitatory SAAs
The neuroexcitatory action of certain SAAs was first demonstrated co-incidentally with that of Lglutamate in the first electrophysiological descriptions of the excitatory actions of acidic amino acids on single neurons in the mammalian CNS [l, 21. The depolarizing action of the SAAs appears to be mediated by at least two ionotropic excitatory amino acid (EAA) receptor subtypes, namely, the N-methyl-u-aspartate (NMDA) receptor and the non-NMDA (RS)-a-amino-3-hydroxy-S-methyl-4-isoxazoleproprionate (AMPA) receptor. On the basis of previous electrophysiological studies, formulation of the relative receptor selectivity of the SAAs has been inconclusive. In particular, there has been considerable controversy concerning the selectivity of action of HCA as an NMDA versus a non-NMDA receptor agonist. The weight of evidence has, until now, supported HCA acting pre-
Figure I
The structures of L-glutamic acid, L-aspartic and and the excitatory sulphurcontaining amino acids
dominantly as an NMDA receptor agonist in certain brain regions [23, 241 and CSA as a preferential non-NMDA agonist [25] . In many earlier studies, however, interpretation of the data was based on the effects of various amino acid agonists following microiontophoretic or bath application using a variety of intact or isolated multicellular preparations. Such systems may distort unequivocal evaluation of the data due to their inability to achieve a uniform concentration of agonist in the extracellular environment because of, e.g., diffusion and uptake of agonist into surrounding neurons and glia. [28] of the affinities of the SAAs at individual EAA receptors has therefore complemented information gained from electrophysiological work in providing valuable data for determining the receptor selectivity of the SAAs. Indeed, the SAAs (both L-and D-enantiomers), when tested in conjunction with a large number of other compounds, have played a key role in studies designed to determine the structural features required for agonist and antagonist binding to NMDA receptors and thus the topology of the transmitter recognition site [30] .
Plasma membrane transport of excitatory SAAs
Rapid removal of amino acid neurotransmitters from the vicinity of receptor-binding sites is an effective way of terminating their synaptic action [31] . For amino acids such as L-glutamate, removal via Na+ -coupled plasma membrane carriers located in both neurons and glia has been demonstrated [32] . A similar situation exists for the SAAs, kinetic characterization and SAA transport having been undertaken using primary cultures of neurons and astrocytes [33] , and synaptosomes [34] , as model in vitro systems. These results are summarized in Table 1 . CSA and CA exhibit a high affinity for the plasma membrane carrier in each preparation 
Signal transduction mechanisms
Biochemical studies related to the neurochemical actions of the SAAs as extracellular signals and the signal transduction mechanisms by which they exert these effects have only recently been undertaken.
SAA-evoked receptor-mediated release of neurotransmitters
A number of workers (for review see [ 15] ), using a variety of brain preparations such as primary neuronal cultures, slices and isolated nerve endings, have demonstrated that the SAAs evoke the release of a variety of transmitters in the absence of additional depolarizing agents. The mechanism of SAAevoked release appears to be dependent on the nature of the brain preparation and the brain region employed. For example, an SAA-evoked, ionotropic EAA receptor-mediated, calcium-dependent release has been demonstrated for ["ID-aspartate and endogenous L-glutamate from primary cultures of mouse cerebellar ('glutamatergic') granule cells [ 39, 401, for ['HI y-aminobutyric acid (GABA) from primary cultures of mouse cortex neurons [39, 411 , and for [ 'Hldopamine from cultured mesencephalic cells [42] . In each case the SAAs were shown to be mixed agonists at EAA receptors, as shown by the attenuation of their effects in the presence of selective NMDA and non-NMDA receptor antagonists. In cortical synaptosomes prepared from rat brain, a calcium-dependent, SAA-evoked release of ['HIGABA (but not endogenous GABA) and of endogenous L-glutamate (but not endogenous Laspartate or exogenously supplied [3H]~~-aspartate) could be demonstrated, although this release could not be attributed to involvement of currently established ionotropic E M receptors [43] . In other studies, an SAA-evoked, dose-dependent release of transmitter could be demonstrated which was neither calcium-dependent nor involved mediation by EAA receptors (see [ 151). A general conclusion to be drawn from these studies is that the SAAs (i) evoke a release of classic transmitters by both calcium-dependent and -independent mechanisms and (ii) that the release by the calcium-dependent process is mediated via characterized ionotropic EAA receptors situated post-synaptically and possibly by another, as yet uncharacterized, receptor situated presynaptically.
In cultures of cortical neurons and of cerebellar granule cells, the SAAs also evoke a distinct component of, respectively, ['HIGABA and ['HIDaspartate release which persists in the absence of extracellular Ca2+ or when voltage-gated Ca2+ channels are blocked [39] [40] [41] 441 . In the case of ["IGABA release from cortical neurons, this Ca2 + -independent component of release is mediated by ionotropic EAA receptors and arises wholly by depolarization-induced reversal of the plasma membrane GABA carrier [41] . In cerebellar granule cells, the major part of the Ca2+-independent release of [-'HID-aspartate is also mediated by EAA receptors and involves, at least partly, reversal of the glutamate carrier [44] . Unequivocal involvement of the plasma membrane glutamate transporter is, however, difficult to establish given the unavailability of selective and non-transportable inhibitors of the carrier.
In these studies [41, 441, Ca2+-independent release refers to the measured release in the absence of extracellular Ca2+. It does not preclude, however, a Ca2+-dependent release arising as a result of the SAA-induced release of Ca2 + from intracellular stores possibly following activation of the metabotropic glutamate receptor (mGlu-R).
The physiological implications, if any, of a Ca2+-independent mode of release is still the subject of much debate and forms the basis of two recent review articles [45, 46] . It has been proposed, for example, that in the absence of axonal firing, a continuous release of transmitters by a Ca2 + -independent mechanism may (i) maintain the sensitivity and proper trophic functions of the post-synaptic regions or (ii) regulate the release of another transmitter from afferent inputs directed at the host cell; e.g. EAA-induced release of GABA may regulate glutamatergic synapses directed to GABAergic neurons. The pathological implications of the Ca2+-independent release are more easy to rationalize; such release may occur either as a consequence of or as a reason for a functional impairment. To take an example, excessive Ca2+ -independent release of EAAs from brain cells could result in overactivation of EAA receptors. Such overstimulation of EAA receptors appears to be the initial trigger which results in a wide variety of neurodegenerative disorders.
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SAA-evoked receptor-mediated production of inositol phosphates
Certain SAAs are known to stimulate the production of inositol phosphates in primary cultures of striatal neurons [47] , in hippocampal slices [48] and in XenoplLs oocytes [49] . In cerebellar granule cells, the SAAs are able to induce the formation of ino- -( k )-1 -amino-1,3 -cyclopentane dicarboxylic acid (a selective agonist of the mGlu-R) (A. Gorman and R. Griffiths, unpublished work). Moreover, the maximal effects of the SAAs were essentially similar to those of L-glutamate and quisqualate but -three-four-fold greater than those of trans-ACPD. Whether or not the SAA-stimulated formation of inositol phosphates arises by mGlu-R, G-protein-coupled phosphoinositide hydrolysis and/or CaZ + activation of phospholipase C, following NMDA receptor activation, is currently under investigation.
SAA-evoked receptor-mediated increases in intracellular free calcium
Activation of glutamate receptor subtypes is accompanied by an increase in the intracellular level of free Ca2+ ([Ca2+Ii) [SO] . Such increases in [Ca2+]i trigger a large variety of Ca2 + -dependent processes which are essential for maintenance of neuronal function. A disturbance in intracellular Ca2+ homeostasis, however, will initiate pathophysiological states contributing to neuronal injury [Sl] . Indeed, a disturbance in intracellular Ca2 
Introduction
Chemical intercellular communication is one of the major mechanisms by which the nervous system transfers information through neuronal networks. Up to now, attention has been paid mainly to the interneuronal communication by means of neurotransmitters operating at synapses, leaving to the 
